Intended for healthcare professionals

Letters Breast screening

Will ductal carcinoma in situ defeat breast cancer screening?

BMJ 2009; 338 doi: (Published 09 March 2009) Cite this as: BMJ 2009;338:b957
  1. John R Benson, consultant breast surgeon1
  1. 1Addenbrooke’s Hospital, Cambridge CB2 0QQ
  1. john.benson{at}

    Gøtzsche and colleagues focus on the inadequacy of patient information leaflets in the NHS breast screening programme.1

    The failure to disclose information on ductal carcinoma in situ has aptly been described by a patient representative as a “closely guarded state secret.” Ductal carcinoma in situ constitutes up to a fifth of …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription